Clinical data | |
---|---|
Other names | ACE-011, MK-7962 |
ATC code |
|
Identifiers | |
CAS Number | |
DrugBank | |
UNII | |
KEGG |
Sotatercept (ACE-011, MK-7962) is a activin signaling inhibitor therapy drug being developed for pulmonary arterial hypertension.[1][2][3][4] It was initially developed to increase bone density[5] and has also been developed for anemia[6][7][8] and multiple myeloma.[9]